ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT04835441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study of ALPN-101 in Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is Phase 2, multinational, randomized, blinded study to evaluate the safety, tolerability, efficacy, immunogenicity, pharmacokinetics and pharmacodynamics of ALPN-101 (acazicolcept) in adults with moderate to severe active systemic lupus erythematosus (SLE)
Study identification
- NCT ID
- NCT04835441
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 76 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 22, 2021 (Actual)
- Primary completion
- Jul 9, 2024 (Actual)
- Completion
- Jul 9, 2024 (Actual)
- Last update posted
- Aug 15, 2025
2021 – 2024
United States locations
- U.S. sites
- 29
- U.S. states
- 12
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site (107) | Anniston | Alabama | 36207 | — |
| Investigational Site (189) | Phoenix | Arizona | 85037 | — |
| Investigational Site (155) | Los Angeles | California | 90022 | — |
| Investigational Site (109) | San Diego | California | 92020 | — |
| Investigational Site (169) | Santa Barbara | California | 93108 | — |
| Investigational Site (106) | DeBary | Florida | 32713 | — |
| Investigational Site (120) | Hialeah | Florida | 33016 | — |
| Investigational Sites (134) | Miami | Florida | 33165 | — |
| Investigational Site (152) | Ormond Beach | Florida | 32174 | — |
| Investigational Site (133) | Plantation | Florida | 33324 | — |
| Investigational Site (190) | Tamarac | Florida | 33321 | — |
| Investigational Site (163) | Tampa | Florida | 33606 | — |
| Investigational Site (173) | Idaho Falls | Idaho | 83404 | — |
| Investigational Site (156) | Skokie | Illinois | 60076 | — |
| Investigational Site (138) | Grand Blanc | Michigan | 48439 | — |
| Investigational Site (164) | Las Vegas | Nevada | 89128 | — |
| Investigational Site (175) | Brooklyn | New York | 11220 | — |
| Investigational Site (115) | Manhasset | New York | 11030 | — |
| Investigational Site (179) | Charlotte | North Carolina | 28277 | — |
| Investigational Site (112) | Crossville | Tennessee | 38555 | — |
| Investigational Site (186) | Memphis | Tennessee | 38119 | — |
| Investigational Site (171) | Baytown | Texas | 77521 | — |
| Investigational Site (143) | Bellaire | Texas | 77401 | — |
| Investigational Site (118) | Colleyville | Texas | 76034 | — |
| Investigational Site (166) | Fort Worth | Texas | 76107 | — |
| Investigational Site (121) | Houston | Texas | 77089 | — |
| Investigational Site (104) | Mesquite | Texas | 75150 | — |
| Investigational Site (162) | San Antonio | Texas | 78215 | — |
| Investigational Site (127) | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04835441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04835441 live on ClinicalTrials.gov.